Q1 2025 Earnings Call Transcript October 24, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.2, expectations ...

SAN DIEGO – ResMed’s revenue increased by 11% to $1.2 billion for the first quarter of 2025. It reported net income of $311.4 million, a 42% increase. “Our first-quarter fiscal year 2025 results ...

Hello, and welcome to the Q1 fiscal year 2025 ResMed Earnings conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) Please note this conference call is ...

The AirFit F40, ResMed's smallest oronasal mask ever ... We believe this mask technology will set a new standard for CPAP, APAP, and bilevel patient interface therapy and will help more people ...

ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...